FFO
WST icon

Fortitude Family Office’s West Pharmaceutical WST Stock Holding History

Fortitude Family Office’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.3K Buy
49
+17
+53% +$4.23K ﹤0.01% 577
2025
Q4 		$8.8K Sell
32
-3
-9% -$821 ﹤0.01% 618
2025
Q3 		$9.18K Buy
35
+23
+192% +$5.59K ﹤0.01% 602
2025
Q2 		$2.63K Buy
12
+1
+9% +$214 ﹤0.01% 1061
2025
Q1 		$2.46K Hold
11
– – ﹤0.01% 891
2024
Q4 		$3.6K Hold
11
– – ﹤0.01% 919
2024
Q3 		$3.3K Hold
11
– – ﹤0.01% 907
2024
Q2 		$3.62K Hold
11
– – ﹤0.01% 688
2024
Q1 		$4.35K Hold
11
– – ﹤0.01% 671
2023
Q4 		$3.87K Buy
+11
New +$3.89K ﹤0.01% 775

Other funds holding WST

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return